Fig. 2From: EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancersTherapeutic targets in ARID1A mutated cancers. Novel targeting of several key regulators in the PI3K/AKT/mTOR pathway and SWI/SNF complex modulate downstream effectors to inhibit cellular proliferation and promote apoptosis (Fig. 2)Back to article page